# FDA Inspection 1314676 - Berkeley Biologics LLC - April 29, 2026

Source: https://www.keypedia.com/records/fda_inspections/berkeley-biologics-llc/f4ebc4b8-f7a8-4bc4-88b5-16bf9b1dea50
Source feed: FDA_Inspections

> FDA Inspection 1314676 for Berkeley Biologics LLC on April 29, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314676
- Company Name: Berkeley Biologics LLC
- Inspection Date: 2026-04-29
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: San Francisco District Office

## Related Documents

- [FDA Inspection 1218588 - 2023-09-25](https://www.keypedia.com/records/fda_inspections/berkeley-biologics-llc/03373494-ad76-49bb-9f0e-95d3f4939f30)
- [FDA Inspection 1145973 - 2021-06-25](https://www.keypedia.com/records/fda_inspections/berkeley-biologics-llc/12fdcc4e-ca24-40f9-80c8-fc56272f6d90)
- [FDA Inspection 1145973 - 2021-06-25](https://www.keypedia.com/records/fda_inspections/berkeley-biologics-llc/86d33efd-61d0-4a8b-8403-69a89025e77d)
- [FDA Inspection 1145973 - 2021-06-25](https://www.keypedia.com/records/fda_inspections/berkeley-biologics-llc/4d89386b-33f8-4f78-aff0-4f036d724760)
- [FDA Inspection 1067125 - 2018-08-28](https://www.keypedia.com/records/fda_inspections/berkeley-biologics-llc/02b931af-443a-42d8-8e90-659c7c26cae3)

Company: https://www.keypedia.com/companies/berkeley-biologics-llc/a6e5270d-1ca1-40d3-830d-422cf9cb6f58

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df